HilleVax Inc. (HLVX)
NASDAQ: HLVX
· Real-Time Price · USD
1.84
-0.02 (-1.08%)
At close: Jun 17, 2025, 2:30 PM
-1.08% (1D)
| Bid | 1.84 |
| Market Cap | 92.26M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -106.5M |
| EPS (ttm) | -2.15 |
| PE Ratio (ttm) | -0.86 |
| Forward PE | -3.08 |
| Analyst | Hold |
| Ask | 1.85 |
| Volume | 63,549 |
| Avg. Volume (20D) | 245,703 |
| Open | 1.83 |
| Previous Close | 1.86 |
| Day's Range | 1.84 - 1.89 |
| 52-Week Range | 1.34 - 15.29 |
| Beta | 0.73 |
About HLVX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HLVX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HLVX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+7.49%
HilleVax shares are trading higher. The stock may ...
Unlock content with
Pro Subscription
11 months ago
-88.34%
HilleVax shares are trading lower after the company announced the NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants.
